Highlights on the risk of pulmonary tuberculosis in patients on ibrutinib treatment: Case report and literature review

EJHaem. 2020 Sep 19;1(2):601-603. doi: 10.1002/jha2.80. eCollection 2020 Nov.

Solo Traoré^{1

2

3}, Mehdi Roumila^{4

5}, Pirayeh Eftekhari⁶, Hassan Farhat³, Fatiha Merabet³, Oumar Guira^{1

2}, Philippe Rousselot^{3

5}, Reza Azarian⁴, Caroline Besson^{3

5

7}

¹ Training and Research Unit in Health Sciences Joseph Ki ZERBO University Ouagadougou Burkina Faso.
² Department of Internal Medicine Yalgado Ouedraogo Teaching Hospital Ouagadougou Burkina Faso.
³ Department of Hematology-Oncology Versailles Hospital Center Le Chesnay France.
⁴ Department of Pneumology Versailles Hospital Center Le Chesnay France.
⁵ Faculty of Medicine University Paris-Saclay UVSQ Montigny-le-Bretonneux France.
⁶ French Regional Pharmacovigilance Center Fernand-Widal Hospital-APHP Paris France.
⁷ CESP, INSERM U1018 University Paris-Saclay UVSQ Villejuif France.

No abstract available